张

张小玲 (Xiaoling Zhang)

nantong university邮箱:zhangxiaoling@ntu.edu.cn

H指数:29

被引数:2,312

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Glycolytic Reprogramming in Parkinson's Disease: From Bioenergetic Crosstalk to Therapeutic Modulation

帕金森病中的糖酵解重编程：从生物能量互作到治疗调控

Medicinal Research Reviews

IF11.6

2026-09-050

PRE

The prospect of suicide biomarkers: from neurobiology to precision prevention

自杀生物标志物的前景：从神经生物学到精准预防

Frontiers in Psychology

IF2.9

2026-03-050

OAAI

Altered static and dynamic functional network connectivity between subcortical nuclei and cortical regions of the default mode network in type 2 diabetes mellitus

Frontiers in Neuroscience

IF3.2

2026-01-280

Concurrent anti-glomerular basement membrane disease and membranous nephropathy: a case report

并发抗肾小球基底膜疾病和膜性肾病：一例病例报告

Frontiers in Medicine

IF3

2025-11-040

OAAI

Efficacy and safety of telitacicept in the treatment of IgA nephropathy: a single-center; real-world study

替洛利生在IgA肾病治疗中的有效性与安全性：一项单中心、真实世界研究

Frontiers in Pharmacology

IF4.8

2025-09-290

OAAI

Algal-bacterial symbiosis strengthens the treatment of high-salinity phenolic wastewater and its molecular mechanism

藻菌共生强化了高盐酚类废水的处理及其分子机制

Journal of Hazardous Materials

IF11.3

2025-09-230

PRE

Cordycepin promotes autophagic degradation of α-synuclein via CacyBP/SIP activation for ameliorating olfactory dysfunction against Parkinson's disease

Cordycepin通过激活CacyBP/SIP促进α-synuclein的自噬性降解，以改善帕金森病中的嗅觉功能障碍。

Free Radical Biology and Medicine

IF8.2

2025-07-080

PRE

Harnessing FDA-approved dipyridamole to inhibit NLRP3 inflammasome and improve outcomes of acute lung injury in sepsis

利用FDA批准的二磷酸腺苷胺抑制NLRP3炎性小体并改善脓毒症急性肺损伤的结局

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2025-07-010

PRE

Distinguishing stroke from transient ischemic attack using plaque characteristics and arterial transit artifacts

通过斑块特征和动脉传输伪影区分卒中与短暂性脑缺血发作

FRONTIERS IN NEUROLOGY

IF2.8

2025-03-210

Serum metabolomics analysis reveals a novel association between maternal metabolism and fetal survival in sows fed diets containing differing methionine levels and sources

ANIMAL NUTRITION

IF7.5

2025-03-010

OAAI

Enhancing prediction of parenchymal hemorrhage type 2 after endovascular treatment in acute ischemic stroke using dual-phase CTA

EUROPEAN JOURNAL OF RADIOLOGY

IF3.3

2025-02-010

OAAI

Mitochondrial dysfunction as a therapeutic strategy for neurodegenerative diseases: Current insights and future directions

线粒体功能障碍作为神经退行性疾病的治疗策略: 当前的见解和未来的方向

AGEING RESEARCH REVIEWS

IF12.4

2024-12-010

PRE

Formononetin Induces Ferroptosis in Activated Hepatic Stellate Cells to Attenuate Liver Fibrosis by Targeting NADPH Oxidase 4

Formononetin通过靶向NADPH氧化酶4诱导活化的肝星状细胞的铁死亡以减轻肝纤维化

PHYTOTHERAPY RESEARCH

IF6.3

2024-10-302

PRE

Self-Produced O2 CNs-Based Nanocarriers of DNA Hydrophobization Strategy Triggers Photodynamic and Mitochondrial-Derived Ferroptosis for Hepatocellular Carcinoma Combined Treatment

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-08-291

PRE

Multidimensional energy poverty and its urban-rural and regional disparities: Evidence from China

多维能源贫困及其城乡和地区差异: 来自中国的证据

JOURNAL OF CLEANER PRODUCTION

IF10

2024-08-011

PRE

RNAi-mediated knockdown of DJ-1 leads to mitochondrial dysfunction via Akt/GSK-3 ß and JNK signaling pathways in dopaminergic neuron-like cells (vol 146, pg 228 - 236, 2019)

BRAIN RESEARCH BULLETIN

IF3.7

2024-04-010

PRE

Vebreltinib: A novel brain-penetrating MET kinase inhibitor demonstrates the mechanism of action and pharmacological anti-tumor activity in diverse patient-derived MET-dysregulated tumor models at clinically relevant drug levels

CANCER RESEARCH

IF16.6

2024-03-220

PRE

Olfactory dysfunction and its related molecular mechanisms in Parkinson's disease

帕金森病的嗅觉障碍及其相关分子机制

NEURAL REGENERATION RESEARCH

IF6.7

2023-07-2016

OAAI

Two-photon excited red-green discoloration bioprobes for monitoring lipid droplets and lipid droplet-lysosomal autophagy

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2023-01-014

PRE

Mangiferin prevents hepatocyte epithelial-mesenchymal transition in liver fibrosis via targeting HSP27-mediated JAK2/STAT3 and TGF-β1/Smad pathway

PHYTOTHERAPY RESEARCH

IF6.3

2022-07-0225

PRE

研究方向

神经药理学（帕金森病）和肝纤维化等相关疾患的药物开发及机理研究抗神经退行性疾病创新药物研发及作用机制研究内实验模型进行筛选，相关活性成分进一步进行临床前评价抗肝纤维化药物的发现及分子生物学研究肝损伤等重大临床疾患的药效物质分离制备分子药理学评估信号通路

Mingxuan Liu

H 指数:22论文数:146被引数:2,310

Nai‐Hong Chen

H 指数:61论文数:400被引数:1.1万

Qian-Hang Shao

H 指数:15论文数:40被引数:678

A. Thomas Look

H 指数:120论文数:621被引数:5.7万

Shizhen Zhu

H 指数:20论文数:119被引数:2,052

Xiaoqun Ge

H 指数:10论文数:23被引数:381

Yiwei Liu

H 指数:21论文数:74被引数:1,634

张

张浩

H 指数:56论文数:674被引数:1.2万

王

王真真

H 指数:31论文数:100被引数:2,919

袁

袁正宏

H 指数:60论文数:294被引数:1.6万